Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women

Journal of the American Geriatrics Society

Volumn 47, Issue 10, 1999, Pages 1171-1175

  Steffens, David C ^a   Norton, Maria C ^b   Plassman, Brenda L ^a   Tschanz, JoAnn T ^b   Wyse, Bonita W ^b   Welsh Bohmer, Kathleen A ^a   Anthony, James C ^c   Breitner, John C S ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UTAH STATE UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Apolipoprotein E; Cognition; Estrogen; Population

Indexed keywords

APOLIPOPROTEIN E; ESTROGEN;

AGED; ALLELE; ARTICLE; COGNITION; ESTROGEN THERAPY; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; POSTMENOPAUSE; RISK FACTOR;

EID: 0032823791     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb05195.x     Document Type: Article

References (35)

1. Brinton RD, Proffitt P, Tran J, Luu R. Equilin, a principal component of the estrogen replacement therapy premarin, increases the growth of cortical neurons via an NMDA receptor-dependent mechanism. Exp Neurol 1997;147:211-220.
2. Green PS, Gridley KE, Simpkins JW. Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett 1996;218:165-168.
3. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-261.
4. Ohkura T, Isse K, Azakawa K et al. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer's type: 7 case reports. Dementia 1995;6:99-107.
5. Schneider LS, Farlow MR, Henderson VW, Pogoda JM. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 1996;46:1580-1584.
6. Tang MX, Jacobs D, Stern Y, Marder K et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348:429-432.
7. Kawas C, Rosnick S, Morrison A, Brookmeyer R et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease in the Baltimore Longitudinal study of aging. Neurology 1997;48:1517-1521.
8. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;10:325-335.
9. Sherwin BB, Phillips S. Estrogen and cognitive functioning in surgically menopausal women. Ann N Y Acad Sci 1990;592:474-475.
10. Phillips S, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-495.
11. Robinson D, Friedman L, Marcus R et al. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994;42:919-922.
12. Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy post-menopausal women. Obstet Gynecol 1994;83:979-983.
13. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993;269:2637-2641.
14. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
15. Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
16. Richards B, Skoletsky J, Shuber AP et al. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet 1993;2:159-163.
17. Norton MC, Breitner JCS, Welsh KA, Wyse BW. Characteristics of nonresponders in a communiry survey of the elderly. J Am Geriatr Soc 1994;42: 1252-1256.
18. Lyon JL, Wetzler HP, Gardner JW et al. Cardiovascular mortality in Mormons and non-Mormons in Utah. Am J Epidemiol 1978;108:357-366.
19. Lyon JL, Gardner JW, Klauber MR et al. Low cancer incidence and mortality in Utah. Cancer 1977;39:2608-2618.
20. Manton KG, Stallard E. Cross-sectional estimates of active life expectancy for the U.S. elderly and oldest-old populations. J Gerontol 1991;46:S170-182.
21. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
22. Gallo JJ, Breitner JC. Alzheimer's disease in the NAS-NRC Registry of aging twin veterans, IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychol Med 1995;25:1211-1219.
23. Silverman JM, Breitner JCS, Mohs RC et al. Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry 1986;143:1279-1282.
24. Szklo M, Cerhan J, Diez-Roux AV et al. Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1996;144:1048-1057.
25. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991;115:455-456.
26. Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's characteristics. J Clin Epidemiol 1993;46:211-219.
27. Derby CA, Hume AL, McPhillips JB et al. Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers. Am J Obstet Gynecol 1995;173:544-550.
28. Matthews KA, Kuller LH, Wing RR et al. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996;143:971-978.
29. Grodstein F. Invited commentary: Can selection bias explain the cardiovascular benefits of estrogen replacement therapy? Am J Epidemiol 1996;143:979-982.
30. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: Estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-545.
31. Hackman BW, Galbraith D. Six-month study of estrogen therapy with piperazine oesterone sulfate and its effects on memory. Curr Med Res Opin 1977;4: 21-27.
32. Fedor-Freybergh P. The influence of estrogen on the well-being and mental performance in climacteric and post-menopausal women. Acta Obstet Gynecol Scand 1977;64(suppl):S5-69.
33. Schmidt P, Fazekas F, Reinhart B et al. Estrogen replacement therapy in older women: A neuropsychological and brain MRI study. J Am Geriatr Soc 1996;44:1307-1313.
34. Rauramo L, Lagerspetz K, Engblom P et al. The effects of castration and peroral estrogen therapy on some psychological functions. Front Horm Res 1975;8:133-151.
35. Sherwin BB. Estrogenic effects on memory in women. Ann N Y Acad Sci 1994;743:213-230.